✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdCost AnalysisProduct QualityPatient AccessDosing Why This MattersCost analysis of CBD gummies affects patient access...
Our Opinion: PA needs to get on board with legalized recreational marijuana
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisPatient AccessRegulatory FrameworkClinical Guidance Why This MattersPennsylvania's potential recreational cannabis legalization would significantly...
Trump DOJ Deregulates Marijuana to the Dismay of Health Experts – The Washington Stand
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFederal RegulationClinical ResearchPatient Access Why This MattersFederal regulatory changes directly impact clinical access...
Trump calls for Congress to amend hemp ban after marijuana reclassification – Colorado Politics
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyHempCbdRegulationPatient Access Why This MattersPolicy changes affecting hemp and cannabis scheduling directly impact patient...
Marijuana advocacy groups meet with state officials following reclassification of state … – Fox 59
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisState RegulationPatient AccessImplementation Why This MattersState-level policy meetings following cannabis reclassification directly impact...
DOJ Schedule III cannabis order creates uncertainty for D.C.’s medical self-certification program
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFederal SchedulingPatient AccessRegulatory Why This MattersSchedule III reclassification creates immediate regulatory uncertainty for...
White House Weighs In On Hemp Legislation As GOP Lawmaker Pushes Accelerated THC …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Hemp PolicyThcRegulationPatient AccessCbd Why This MattersRegulatory uncertainty around hemp-derived THC products directly impacts...
DEA Reschedules FDA-Approved Marijuana Products and State-Licensed Medical … – JD Supra
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFda RegulationMedical CannabisPatient AccessScheduling Why This MattersThe DEA's rescheduling of FDA-approved marijuana products creates...
U.S. reclassifies medical marijuana as Schedule III, easing research barriers and tax burdens
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchMedical CannabisRegulationPatient Access Why This MattersSchedule III reclassification removes the primary federal barrier to...
‘Less red tape:’ Public and political perception of cannabis continues to change – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPatient AccessMedical CannabisRegulationPublic Health Why This MattersShifting public and political attitudes toward cannabis directly...